Rexis Biotech Inc.

CIK: 2000970DEIncorporated: 2022-01-24

Current Offering

$50,000
Target Amount
$1,235,000
Maximum Amount
2024-04-29
Deadline

Security Details

Type: Preferred Stock
Price per share: $1.25
Shares offered: 44,248+

Offering Costs

Cash commission: 8%
7.5% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.
Equity compensation: 0%
No

Financial Reports

Offering via Wefunder

Offering History

As of 2023-12-08
Raising $50,000 -$1,235,000 via 44,248+ shares of preferred Stock at $1.25 per share
Deadline: 2024-04-29
Filing date2023-12-08
Current employees7
Act received most recent fiscal year$0.00
Act received prior fiscal year$0.00
Cash equi most recent fiscal year$19.00
Cash equi prior fiscal year$0.00
Cost goods sold most recent fiscal year$100,122
Cost goods sold prior fiscal year$0.00
Long term debt most recent fiscal year$0.00
Long term debt prior fiscal year$0.00
Net income most recent fiscal year-$76.00
Net income prior fiscal year$0.00
Revenue most recent fiscal year$191,341
Revenue prior fiscal year$0.00
Short term debt most recent fiscal year$0.00
Short term debt prior fiscal year$0.00
Tax paid most recent fiscal year$0.00
Tax paid prior fiscal year$0.00
Total asset most recent fiscal year$19.00
Total asset prior fiscal year$0.00

Company Information

Corporation
DE
2022-01-24

Latest Metrics

Employees7
Total Assets$19.00
Cash on Hand$19.00
Revenues$191,341
Net Income-$76.00

Crowdfunding Portals

This company is raising funds through this portal